Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.29−0.01 (-0.23%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Precigen cash
Cash and short-term investments held at the end of each period.
Precigen's cash was $38.70M at Jun 30, 2026. For fiscal 2025 it was $100.37M, up 2.5% from the year before. Over ten years it grew -8.3% a year on average. The highest annual figure on record is $244.20M in fiscal 2016.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.37M | +2.5% |
| FY2024 | Dec 31, 2024 | $97.91M | +55.7% |
| FY2023 | Dec 31, 2023 | $62.90M | -36.9% |
| FY2022 | Dec 31, 2022 | $99.69M | -13.8% |
| FY2021 | Dec 31, 2021 | $115.58M | +14.9% |
| FY2020 | Dec 31, 2020 | $100.58M | +29.5% |
| FY2019 | Dec 31, 2019 | $77.69M | -65.1% |
| FY2018 | Dec 31, 2018 | $222.46M | +171.9% |
| FY2017 | Dec 31, 2017 | $81.82M | -66.5% |
| FY2016 | Dec 31, 2016 | $244.20M | +2.5% |
| FY2015 | Dec 31, 2015 | $238.31M | +105.5% |
| FY2014 | Dec 31, 2014 | $115.96M | -34.7% |
| FY2013 | Dec 31, 2013 | $177.49M | +1564.5% |
| FY2012 | Dec 31, 2012 | $10.66M | -45.7% |
| FY2011 | Dec 31, 2011 | $19.63M | +13.0% |
| FY2010 | Dec 31, 2010 | $17.37M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $38.70M | -35.2% |
| Q1 FY2026 | Mar 31, 2026 | $56.74M | -29.9% |
| Q4 FY2025 | Dec 31, 2025 | $100.37M | +2.5% |
| Q3 FY2025 | Sep 30, 2025 | $123.64M | +331.9% |
| Q2 FY2025 | Jun 30, 2025 | $59.75M | +205.9% |
| Q1 FY2025 | Mar 31, 2025 | $80.99M | +81.0% |
| Q4 FY2024 | Dec 31, 2024 | $97.91M | +55.7% |
| Q3 FY2024 | Sep 30, 2024 | $28.63M | -61.3% |
| Q2 FY2024 | Jun 30, 2024 | $19.54M | -78.0% |
| Q1 FY2024 | Mar 31, 2024 | $44.76M | -62.2% |
| Q4 FY2023 | Dec 31, 2023 | $62.90M | -36.9% |
| Q3 FY2023 | Sep 30, 2023 | $74.01M | -52.0% |
| Q2 FY2023 | Jun 30, 2023 | $88.84M | -26.8% |
| Q1 FY2023 | Mar 31, 2023 | $118.30M | +5.1% |
| Q4 FY2022 | Dec 31, 2022 | $99.69M | -13.8% |
| Q3 FY2022 | Sep 30, 2022 | $154.14M | +34.2% |
| Q2 FY2022 | Jun 30, 2022 | $121.35M | +5.0% |
| Q1 FY2022 | Mar 31, 2022 | $112.56M | +6.1% |
| Q4 FY2021 | Dec 31, 2021 | $115.58M | +14.9% |
| Q3 FY2021 | Sep 30, 2021 | $114.84M | +1.2% |
| Q2 FY2021 | Jun 30, 2021 | $115.55M | -13.4% |
| Q1 FY2021 | Mar 31, 2021 | $106.12M | -29.1% |
| Q4 FY2020 | Dec 31, 2020 | $100.58M | +29.5% |
| Q3 FY2020 | Sep 30, 2020 | $113.54M | +26.6% |
| Q2 FY2020 | Jun 30, 2020 | $133.42M | +6.1% |
| Q1 FY2020 | Mar 31, 2020 | $149.58M | -17.6% |
| Q4 FY2019 | Dec 31, 2019 | $77.69M | -65.1% |
| Q3 FY2019 | Sep 30, 2019 | $89.71M | -64.7% |
| Q2 FY2019 | Jun 30, 2019 | $125.80M | +45.9% |
| Q1 FY2019 | Mar 31, 2019 | $181.63M | +42.3% |
| Q4 FY2018 | Dec 31, 2018 | $222.46M | +171.9% |
| Q3 FY2018 | Sep 30, 2018 | $254.00M | +118.7% |
| Q2 FY2018 | Jun 30, 2018 | $86.25M | -47.6% |
| Q1 FY2018 | Mar 31, 2018 | $127.65M | -39.8% |
| Q4 FY2017 | Dec 31, 2017 | $81.82M | -66.5% |
| Q3 FY2017 | Sep 30, 2017 | $116.15M | -50.9% |
| Q2 FY2017 | Jun 30, 2017 | $164.58M | – |
| Q1 FY2017 | Mar 31, 2017 | $212.22M | – |
| Q4 FY2016 | Dec 31, 2016 | $244.20M | – |
| Q3 FY2016 | Sep 30, 2016 | $236.55M | – |
See a number that looks wrong?